| First Author | Hong H | Year | 2020 |
| Journal | PLoS Genet | Volume | 16 |
| Issue | 11 | Pages | e1009168 |
| PubMed ID | 33137086 | Mgi Jnum | J:297550 |
| Mgi Id | MGI:6473584 | Doi | 10.1371/journal.pgen.1009168 |
| Citation | Hong H, et al. (2020) In vivo miRNA knockout screening identifies miR-190b as a novel tumor suppressor. PLoS Genet 16(11):e1009168 |
| abstractText | MicroRNAs (miRNAs) play important roles in the development of various cancers including lung cancer which is one of the devastating diseases worldwide. How miRNAs function in de novo lung tumorigenesis remains largely unknown. We here developed a CRISPR/Cas9-mediated dual guide RNA (dgRNA) system to knockout miRNAs in genetically engineered mouse model (GEMM). Through bioinformatic analyses of human lung cancer miRNA database, we identified 16 downregulated miRNAs associated with malignant progression and performed individual knockout with dgRNA system in KrasG12D/Trp53L/L (KP) mouse model. Using this in vivo knockout screening, we identified miR-30b and miR-146a, which has been previously reported as tumor suppressors and miR-190b, a new tumor-suppressive miRNA in lung cancer development. Over-expression of miR-190b in KP model as well as human lung cancer cell lines significantly suppressed malignant progression. We further found that miR-190b targeted the Hus1 gene and knockout of Hus1 in KP model dramatically suppressed lung tumorigenesis. Collectively, our study developed an in vivo miRNA knockout platform for functionally screening in GEMM and identified miR-190b as a new tumor suppressor in lung cancer. |
